Differentiation of Disulfiram Effects on Central Catecholamines and Hepatic Ethanol Metabolism
Open accessThe DOI matches its Crossref record.
Abstract
Disulfiram is used in the treatment of chronic alcoholism, because of the unpleasant symptoms it provokes after ethanol intake. The underlying mechanism is believed to be the accumulation of acetaldehyde in the blood, due to inhibition of the liver aldehyde dehydrogenases. In addition, it is known that disulfiram also has some neurotoxic properties. The aim of our study was to investigate the relationship between the pharmacological and neurotoxicological properties of disulfiram with respect to the doses applied. Increasing doses of disulfiram (25, 50, 75, 100 and 150 mg/kg) were administered intraperitoneally to Wistar rats and the hepatic enzyme activities of alcohol and aldehyde dehydrogenases were measured. Also, in two brain subregions (midbrain and hypothalamus) the levels of noradrenaline, dopamine, 3,4‐dihydroxyphenylacetic acid and homovanillic acid were determined. The higher dose of disulfiram (150 mg/kg) produced lethal effects in all treated animals. Aldehyde dehydrogenase activities were inhibited by disulfiram in a dose‐dependent way, while alcohol dehydrogenase was not affected at all. Concerning the levels of brain biogenic amines, disulfiram produced a significant reduction in noradrenaline and an increase in dopamine levels in both structures of the brain, in a dose‐dependent way. However, the lowest dose applied (25 mg/kg) had no effects on brain catecholamines. It is known that high doses of disulfiram may cause severe encephalopathy and peripheral neuropathy in humans, which could be attributed to the impairment of the metabolism of brain biogenic amines, due to inhibition of dopamine‐β‐hydroxylase. Our experimental data show that disulfiram affects the level of brain biogenic amines at dose levels higher than those inhibiting the activity of aldehyde dehydrogenase. Therefore, in clinical practice ‘disulfiram reaction’ could still be achieved with a low dosage regimen not producing neurotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
There and Back Again: A Tale of Norepinephrine and Drug Addiction
Weinshenker, D., & Schroeder, J. P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 350
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
“Patients diagnosed with PTSD receiving disulfiram responded better than non-PTSD patients, possibly because of disulfiram inhibition of DA beta-hydroxylase in the CNS, potentially resulting in an excess of DA and decreased synthesis of norepinephrine [232].”
Naltrexone and Disulfiram in Patients With Alcohol Dependence and Current Depression
Petrakis, I., Ralevski, E., Nich, C., Levinson, C., Carroll, K., Poling, J., & Rounsaville, B. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b13e3180337fcb · Cited by 66
Schottenfeld, R. S., Chawarski, M. C., Cubells, J. F., George, T. P., Lappalainen, J., & Kosten, T. R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.12.007 · Cited by 31
de Corde-Skurska, A., Krzascik, P., Lesniak, A., Sacharczuk, M., Nagraba, L., & Bujalska-Zadrozny, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084057 · Cited by 6
“Such high doses of DSF carry a greater risk of hepatotoxicity and may additionally cause disturbances in catecholamine levels, leading to neurotoxic effects [21], whereas our study demonstrated that 25 mg/kg DSF is sufficient enough to exert an effect of similar magnitude when given orally, which potentially lowers th…”
Background
Metadata
- Authors
- Karamanakos, P. N., Pappas, P., Stephanou, P., & Marselos, M.
- Venue
- Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 2001-02
- Volume
- 88
- Issue
- 2
- Pages
- 106-110
- ISSN
- 0901-9928 (ISSN-L)
- OpenAlex
- W2044761523
- Cited by
- 65
- References
- 0
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differentiation of Disulfiram Effects on Central Catecholamines and Hepatic Ethanol Metabolism. https://app.cochat.ai/papers/10.1034/j.1600-0773.2001.088002106.x
- The paper
- Karamanakos, P. N., Pappas, P., Stephanou, P., & Marselos, M. (2001). Differentiation of Disulfiram Effects on Central Catecholamines and Hepatic Ethanol Metabolism. Pharmacology & Toxicology. https://doi.org/10.1034/j.1600-0773.2001.088002106.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.